Question 1

What is the catalog number for EKI2 Antibody?

Accepted Answer

The catalog number for EKI2 Antibody is 8C11763-AAT.

Question 2

What sizes are available for EKI2 Antibody?

Accepted Answer

EKI2 Antibody is available in the following size(s): 50 µg.

Question 3

Is EKI2 Antibody in stock?

Accepted Answer

EKI2 Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures EKI2 Antibody?

Accepted Answer

EKI2 Antibody is manufactured by AAT Bioquest.

Question 5

What is the estimated delivery time for EKI2 Antibody?

Accepted Answer

Estimated delivery time for EKI2 Antibody is approximately 15 business day(s), depending on your location.

Question 6

What is EKI2 Antibody used for?

Accepted Answer

EKI2 Antibody

Question 7

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 8

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 9

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

EKI2 Antibody

Product Specifications

H Phrases

R Phrases

Host

Reactivity

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Human OR4K3 activation kit by CRISPRa

3-(Salicyloylamino)-1,2,4-triazole

Mycophenolic Acid-d3 Acyl-Beta-D-glucuronide

G CSF (CSF3) Mouse Monoclonal Antibody [Clone ID: OTI1E1]

Uroplakin 1A (Urothelial Differentiation Marker) (UPK1A/2924), 0.2mg/mL

Capn6 Mouse Gene Knockout Kit (CRISPR)